SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ethos Technologies Inc. (LIFE) has a negative trailing P/E of -15.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 18.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -6.54%, forward earnings yield 5.41%. PEG 0.07 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.07); analyst target implies upside (+56.6%).
- Forward P/E 18.5 — analysts expect a return to profitability with estimated EPS of $0.79 for FY2027.
- PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield -6.54% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 5.41% as earnings recover.
- Analyst consensus target $23.00 (+56.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 40/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LIFE
Valuation Multiples
P/E (TTM)-15.3
Forward P/E18.5
PEG Ratio0.07
Forward PEG0.07
P/B Ratio15.74
P/S Ratio-182.48
EV/EBITDA-10.2
Per Share Data
EPS (TTM)$-0.85
Forward EPS (Est.)$0.79
Book Value / Share$0.83
Revenue / Share$-0.05
FCF / Share$-0.75
Yields & Fair Value
Earnings Yield-6.54%
Forward Earnings Yield5.41%
Dividend Yield0.00%
SharesGrow IV$-16.77 (-214.2%)
Analyst Target$23.00 (+56.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-28.44 |
$0.00 |
$-47.97M |
- |
| 2016 |
$-34.20 |
$0.00 |
$-57.86M |
- |
| 2017 |
$-26.13 |
$0.00 |
$-48.21M |
- |
| 2018 |
$-16.11 |
$0.00 |
$-34.52M |
- |
| 2019 |
$-6.63 |
$422K |
$-22.24M |
-5269.4% |
| 2020 |
$-1.63 |
$10.46M |
$-14.96M |
-143.1% |
| 2021 |
$-1.70 |
$0.00 |
$-32.46M |
- |
| 2022 |
$-1.56 |
$10.39M |
$-44.28M |
-426.3% |
| 2023 |
$-0.94 |
$353K |
$-50.39M |
-14274.5% |
| 2024 |
$-0.84 |
$235K |
$-64.02M |
-27243.8% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$-0.04 |
$-0.53 – $0.66 |
$81.74M |
$81.74M – $81.74M |
5 |
| 2027 |
$0.79 |
$0.79 – $0.79 |
$184.67M |
$184.67M – $184.67M |
1 |
| 2028 |
$2.76 |
$2.76 – $2.76 |
$429.18M |
$429.18M – $429.18M |
2 |
